AlzChem Group AG
XETRA:ACT
AlzChem Group AG
XETRA:ACT
Price:
157.4
EUR
-3.32%
Market Closed
Market Cap:
€1.6B
Relative Value
The Relative Value of one
ACT
stock under the Base Case scenario is
64.54
EUR.
Compared to the current market price of 157.4 EUR,
AlzChem Group AG
is
Overvalued by 59%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ACT
Relative Value
Base Case
64.54
EUR
Overvaluation 59%
Multiples Across Competitors
ACT Competitors Multiples
AlzChem Group AG Competitors
AlzChem Group AG Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DE |
|
AlzChem Group AG
XETRA:ACT
|
1.6B EUR | 2.8 | 25.1 | 13 | 16.7 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
79.9B USD | 3.4 | 31.1 | 20.2 | 23.8 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
78.1B USD | 4.9 | 37.6 | 21.9 | 29.3 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
11.5T JPY | 4.5 | 23.7 | 11.6 | 16 | |
| JP |
Y
|
Yasuhara Chemical Co Ltd
TSE:4957
|
10.8T JPY | 1 | 10.5 | 5.8 | 7.1 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
280B CNY | 1.6 | 25.2 | 21.6 | 21.6 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
25.6B CHF | 3.4 | 23.9 | 16.7 | 21.2 | |
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK | 9.3 | 54.8 | 28.9 | 37.9 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.1T INR | 6.2 | 55.5 | 33.3 | 40.9 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
23.3B USD | 1.5 | 14.8 | 10.3 | 12.8 | |
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR | 1.6 | 17.3 | 10.2 | 14.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
